More than two-thirds of people taking blood thinners take direct oral anticoagulants, or DOACs, which are under- or over-prescribed in up to one in eight patients. A new study finds that most prescribing issues for DOACs occur after a provider writes the initial prescription. Researchers say the findings highlight why patients on DOACs need to be monitored consistently.
Tag: DOAC
DOACs more effective, cost-effective compared to LMWH for cancer-associated thrombosis
A cost-effectiveness analysis comparing direct oral anticoagulants (DOACs) to low-molecular-weight heparin (LMWH) found that DOACs are both more medically effective and cost-effective than LMWH when treating cancer-associated thrombosis (CAT). These findings may inform decisions on the clinical level as well as policy decisions. The analysis is published in Annals of Internal Medicine.
Two Blood Thinners at Once: More Risk with the Same Reward
For some patients, adding aspirin to a direct oral anticoagulant is an equation that rarely adds up.
Instrumentation Laboratory Receives US FDA Marketing Authorization for the First Apixaban Diagnostic Test
Instrumentation Laboratory Receives US FDA Marketing Authorization for the First Apixaban Diagnostic Test